• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CEUS/CT/MRI 对肝细胞癌的现场诊断能力(2019-2022):一项多中心研究。

On-Site Diagnostic Ability of CEUS/CT/MRI for Hepatocellular Carcinoma (2019-2022): A Multicenter Study.

机构信息

Department of Interventional Ultrasound, Chinese PLA General Hospital, Beijing, China.

Department of Medical Ultrasound, Peking University Shenzhen Hospital, Shenzhen, China.

出版信息

J Ultrasound Med. 2023 Dec;42(12):2825-2838. doi: 10.1002/jum.16321. Epub 2023 Sep 15.

DOI:10.1002/jum.16321
PMID:37713625
Abstract

OBJECTIVES

To compare the on-site diagnostic performance of contrast-enhanced ultrasound (CEUS), computed tomography (CECT), and magnetic resonance imaging (CEMRI) for hepatocellular carcinoma (HCC) across diverse practice settings.

METHODS

Between May 2019 and April 2022, a total of 2085 patients with 2320 pathologically confirmed focal liver lesions (FLLs) were enrolled. Imaging reports were compared with results from pathology analysis. Diagnostic performance was analyzed in defined size, high-risk factors for HCC, and hospital volume categories.

RESULTS

Three images achieved similar diagnostic performance in classifying HCC from 16 types of FLLs, including HCC ≤2.0 cm. For HCC diagnosis at low-volume hospitals and HCC with high-risk factors, the accuracy and specificity of CEUS were comparable to CECT and CEMRI, while the sensitivity of CEUS (77.4 and 89.5%, respectively) was inferior to CEMRI (87.0 and 92.8%, respectively). The diagnostic accuracy of CEUS + CEMRI and CEUS + CECT increased by 7.8 and 6.2% for HCC ≤2.0 cm, 8.0 and 5.0% for HCC with high-risk factors, and 7.4 and 5.5% for HCC at low-volume hospitals, respectively, compared with CEMRI/CECT alone.

CONCLUSIONS

Compared with CECT and CEMRI, CEUS provides adequate diagnostic performance in clinical first-line applications at high-volume hospitals. Moreover, a higher diagnostic performance for HCC is achieved by combining CEUS with CECT/CEMRI compared with any single imaging technique.

摘要

目的

比较对比增强超声(CEUS)、计算机断层扫描(CECT)和磁共振成像(CEMRI)在不同实践环境下对肝细胞癌(HCC)的现场诊断性能。

方法

2019 年 5 月至 2022 年 4 月,共纳入 2085 例 2320 例经病理证实的局灶性肝病变(FLL)患者。将影像学报告与病理分析结果进行比较。在定义的大小、HCC 的高危因素和医院容量类别中分析诊断性能。

结果

三种图像在将 HCC 从 16 种 FLL 中分类方面表现出相似的诊断性能,包括 HCC≤2.0cm。对于低容量医院的 HCC 和具有高危因素的 HCC,CEUS 的准确性和特异性与 CECT 和 CEMRI 相当,而 CEUS 的敏感性(分别为 77.4%和 89.5%)低于 CEMRI(分别为 87.0%和 92.8%)。对于 HCC≤2.0cm、HCC 具有高危因素和 HCC 低容量医院,CEUS+CEMRI 和 CEUS+CECT 的诊断准确性分别比 CEMRI/CECT 单独使用提高了 7.8%和 6.2%、8.0%和 5.0%以及 7.4%和 5.5%。

结论

与 CECT 和 CEMRI 相比,CEUS 在大容量医院的临床一线应用中提供了足够的诊断性能。此外,与任何单一成像技术相比,CEUS 与 CECT/CEMRI 相结合可实现更高的 HCC 诊断性能。

相似文献

1
On-Site Diagnostic Ability of CEUS/CT/MRI for Hepatocellular Carcinoma (2019-2022): A Multicenter Study.CEUS/CT/MRI 对肝细胞癌的现场诊断能力(2019-2022):一项多中心研究。
J Ultrasound Med. 2023 Dec;42(12):2825-2838. doi: 10.1002/jum.16321. Epub 2023 Sep 15.
2
Contrast-enhanced ultrasound using SonoVue® (sulphur hexafluoride microbubbles) compared with contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging for the characterisation of focal liver lesions and detection of liver metastases: a systematic review and cost-effectiveness analysis.超声造影使用声诺维®(六氟化硫微泡)与对比增强计算机断层扫描和对比增强磁共振成像在局灶性肝脏病变的特征描述和肝转移检测中的比较:系统评价和成本效益分析。
Health Technol Assess. 2013 Apr;17(16):1-243. doi: 10.3310/hta17160.
3
Comparison of contrast enhanced ultrasound and contrast enhanced CT or MRI in monitoring percutaneous thermal ablation procedure in patients with hepatocellular carcinoma: a multi-center study in China.超声造影与对比增强CT或MRI在监测肝细胞癌患者经皮热消融术中的比较:一项中国多中心研究
Ultrasound Med Biol. 2007 Nov;33(11):1736-49. doi: 10.1016/j.ultrasmedbio.2007.05.004. Epub 2007 Jul 16.
4
Fusion imaging of contrast-enhanced ultrasound and contrast-enhanced CT or MRI before radiofrequency ablation for liver cancers.肝癌射频消融术前超声造影与CT或MRI增强造影的融合成像
Br J Radiol. 2016 Nov;89(1067):20160379. doi: 10.1259/bjr.20160379. Epub 2016 Sep 14.
5
Image fusion of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) using volume navigation for detection, characterization and planning of therapeutic interventions of liver tumors.使用容积导航对肝脏肿瘤进行治疗干预的检测、特征描述和规划,将对比增强超声(CEUS)与计算机断层扫描(CT)或磁共振成像(MRI)进行图像融合。
Clin Hemorheol Microcirc. 2011;49(1-4):67-81. doi: 10.3233/CH-2011-1458.
6
Contrast-enhanced ultrasound LI-RADS 2017: comparison with CT/MRI LI-RADS.对比增强超声 LI-RADS 2017:与 CT/MRI LI-RADS 的比较。
Eur Radiol. 2021 Feb;31(2):847-854. doi: 10.1007/s00330-020-07159-z. Epub 2020 Aug 15.
7
Diagnostic values of contrast-enhanced MRI and contrast-enhanced CT for evaluating the response of hepatocellular carcinoma after transarterial chemoembolisation: a meta-analysis.对比增强 MRI 和 CT 对评价经肝动脉化疗栓塞后肝细胞癌反应的诊断价值:一项荟萃分析。
BMJ Open. 2024 Apr 5;14(4):e070364. doi: 10.1136/bmjopen-2022-070364.
8
Analysis of comparative performance of CEUS and CECT/MR LI-RADS classification: Can CEUS dichotomize LI-RADS indeterminate lesions on CT or MRI?CEUS 与 CECT/MR LI-RADS 分类效能对比分析:CEUS 能否对 CT 或 MRI 上 LI-RADS 不确定病变进行二分类?
Clin Imaging. 2020 Jun;62:63-68. doi: 10.1016/j.clinimag.2020.02.002. Epub 2020 Feb 8.
9
Differences between CEUS LI-RADS and CECT LI-RADS in the diagnosis of focal liver lesions in patients at risk for HCC.CEUS LI-RADS 与 CECT LI-RADS 在 HCC 高危患者局灶性肝脏病变诊断中的差异。
BMC Med Imaging. 2023 Sep 11;23(1):122. doi: 10.1186/s12880-023-01088-1.
10
Diagnostic sensitivity of imaging modalities for hepatocellular carcinoma smaller than 2 cm.小于 2cm 的肝细胞癌的影像学诊断灵敏度。
World J Gastroenterol. 2010 Sep 7;16(33):4187-92. doi: 10.3748/wjg.v16.i33.4187.